1Cameron NE,Eaton SE,Cotter MA,et al.Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.Diabetologia,2001,44:1973～1988. 被引量：1
2Cameron NE,Cotter MA.Metabolic and vascular factors in the pathogenesis of diabetic neuropathy.Diabetes,1997,46(2):31～37. 被引量：1
4Zochodne DW.Diabetic neuropathies:features and mechanisms.Brain Pathol,1999,9(2):369～391. 被引量：1
5Vasan S,Foiles PG,Founds HW.Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links.Expert-Opin-Investig Drugs,2001,10:1977～1987. 被引量：1
7Vinik A.Diabetic neuropathy:pathogenesis and therapy.Am J Med,1999,107(2):17～26. 被引量：1
8Ishii DN.Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy.Brain Res,1995,20:47～67. 被引量：1
9Zhuang HX,Snyder CK,Pu SF.Insulin-like growth factors reverse or arrest diabetic neuropathy:effects on hyperalgesia and impaired nerve regeneration in rats.Exp Neurol,1996,140(2):198～205. 被引量：1
10Shigeta H,Yamaguchi M,Nakano Y,et al.Serum autoantibodies against sulfatide and phospholipid in NIDDM patients with diabetic neuropathy.Diabetes Care,1997,20(12):1896～1899. 被引量：1
